IGF-1 does not rise with oral or sublingual sermorelin: IGF-1 is the measurable marker of growth hormone activity
GLP-1 receptors are found throughout the body, which is why these medications are being studied for a wide range of conditions, including: Cardiovascular disease Kidney disease Peripheral artery disease Sleep apnea Osteoarthritis Metabolic liver disease Now the question is are these benefits driven primarily by weight loss, or do GLP-1s offer direct physiological effects
The water molecule activated by Glu235 acts as a primary proton acceptor by abstracting a proton from the hydroxyl group of an incoming phenolic substrate, which is subsequently transferred to the carboxylic group of the conserved glutamic acid 59
General MNT recommendations for adults taking antiobesity medications include an intake of 1,200 to 1,800 calories/day depending on sex and activity level
The presentation addresses the context of war-related crises in Ukraine, viewed as a complex security, socio-economic, and environmental disaster
